Skip to main content

Essential Thrombocythemia

Rare

Blood Disorders

Essential Thrombocythemia is treated with 3 medications in our database, including Anagrelide, anagrelide, FERRIPROX. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Takeda, Chiesi reinforcement _Self-correction:_ The user asked for the primary manufacturer/company that owns the rights. Chiesi is the entity. Final string: Chiesi. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Essential Thrombocythemia treatment below.

What help exists for Essential Thrombocythemia

6

drugs indexed

4

with copay cards

4

with patient assistance

3

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Essential Thrombocythemia

6 total

🎟 = copay card Β· πŸ’™ = patient assistance program

Prior authorization patterns for Essential Thrombocythemia drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

Grants for Essential Thrombocythemia patients

4 total Β· 3 open

Essential Thrombocythemia is a rare disease β€” more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare β†’